UPDATE: Biogen Idec (BIIB) Completes Strategic Review Without Sale
Tweet Send to a Friend
Biogen Idec Inc. (NASDAQ: BIIB) said The Board of Directors of complated the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


